JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40810

Anti-Glycogen synthase 1/GYS1 antibody [EP817Y]

4

(6 Reviews)

|

(33 Publications)

Rabbit Recombinant Monoclonal Glycogen synthase 1/GYS1 antibody. Suitable for WB and reacts with Human samples. Cited in 33 publications.

View Alternative Names

GYS, GYS1, Glycogen synthase 1

3 Images
Flow Cytometry (Intracellular) - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)

Flow cytometry overlay histogram showing wild-type HeLa (green line) and GYS1 knockout HeLa stained with ab40810 (magenta line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab40810) (1x 106 in 100μl at 0.04 μg/ml (1/15800)) for 30min at 22°C.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.

Isotype control antibody was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control in HeLa WT cells (black line) and HeLa-GYS1 KO cells (grey line), used at the same concentration and conditions as the primary antibody.

Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.

This antibody gave a positive signal in wild-type HeLa fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)
  • WB

Lab

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)

ab40810 Recombinant Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] was shown to specifically react with Glycogen synthase 1/GYS1 in HeLa wild-type cells (ab255928). Loss of signal was observed when knockout cell line ab265388 (knockout cell lysate ab257462) was used. Wild-type and Glycogen synthase 1/GYS1 knockout samples were subjected to SDS-PAGE. ab40810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (ab40810) at 1/10000 dilution

Lane 1:

Wild-type HeLa lysate at 20 µg

Lane 2:

Glycogen synthase 1/GYS1 knockout HeLa lysate at 20 µg

Lane 2:

Western blot - Human GYS1 (Glycogen synthase 1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-gys1-glycogen-synthase-1-knockout-hela-cell-line-ab265388'>ab265388</a>)

Lane 3:

HEK-293 lysate at 20 µg

Lane 4:

Daudi lysate at 20 µg

Predicted band size: 84 kDa

Observed band size: 80 kDa

false

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)
  • WB

Unknown

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (AB40810)

All lanes:

Western blot - Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] (ab40810) at 1/50000 dilution

All lanes:

HeLa cell lysate at 10 µg

Predicted band size: 84 kDa

Observed band size: 85 kDa

false

  • Carrier free

    Anti-Glycogen synthase 1/GYS1 antibody [EP817Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP817Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "1/50 - 1/1000", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glycogen synthase 1 (GYS1) also known as muscle glycogen synthase catalyzes the synthesis of glycogen from glucose. It adds glucose units from UDP-glucose to the non-reducing ends of glycogen chains facilitating glycogen elongation. The molecular mass of GYS1 is approximately 85 kDa. It is predominantly expressed in skeletal muscle tissue providing energy storage primarily in the form of glycogen. GYS1 is regulated through phosphorylation wherein it undergoes inactive to active conformational changes.
Biological function summary

This enzyme plays a critical role in the energy storage mechanism of muscle tissues. GYS1 functions as a part of the glycogen synthase complex interacting with various glycogen-associated proteins to modulate its activity. These interactions control the enzyme's affinity for its substrate and its susceptibility to regulatory signals like phosphorylation affecting glycogen synthesis efficiency. Through its activity GYS1 ensures a readily available reserve of glucose in muscle tissues for rapid energy production when required.

Pathways

Glycogen synthase 1 is a central component of the glycogen metabolism pathway. It acts alongside other enzymes such as glycogen phosphorylase which catalyzes glycogen breakdown. The balance between GYS1 and glycogen phosphorylase determines the rate of glycogen turnover within cells. GYS1 is further regulated by the insulin signaling pathway where insulin promotes glycogen synthesis by altering GYS1 activity alongside proteins like AKT influencing glucose homeostasis and energy management in tissues.

Dysregulation of GYS1 activity often associates with glycogen storage diseases notably Type 0 where deficiencies in glycogen storage lead to episodes of low blood sugar and reduced exercise capacity. Furthermore aberrations in GYS1 function contribute to insulin resistance and Type 2 diabetes conditions linked with impaired glucose metabolism. Altered GYS1 activity impacts proteins like glycogen phosphorylase affecting overall glycogen metabolism balance and contributing to metabolic disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Glycogen synthase participates in the glycogen biosynthetic process along with glycogenin and glycogen branching enzyme. Extends the primer composed of a few glucose units formed by glycogenin by adding new glucose units to it. In this context, glycogen synthase transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan.
See full target information GYS1

Publications (33)

Recent publications for all applications. Explore the full list and refine your search

Cell biochemistry and function 43:e70108 PubMed40770889

2025

Osteoking Ameliorates Type 2 Diabetes Osteoporosis by Enhancing Osteoblast Differentiation via PI3K/AKT/GSK-3β Pathway Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Li,Jiangli Lu,Peijin Wang,Yulan Zhao,Yi Yang,Jianlin Jiao,Zhongyi Qian,Limei Wang,Hong Zheng

Journal of extracellular vesicles 14:e70078 PubMed40366616

2025

Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning.

Applications

Unspecified application

Species

Unspecified reactive species

Ye Yuan,Hai Jiang,Rui Xue,Xiao-Jun Feng,Bi-Feng Liu,Lian Li,Bo Peng,Chen-Shuo Ren,Shi-Min Li,Na Li,Min Li,Dian-Bing Wang,Xian-En Zhang

Disease models & mechanisms 17: PubMed39301689

2024

Neuromuscular junction dysfunction in Lafora disease.

Applications

Unspecified application

Species

Unspecified reactive species

Monica Shukla,Deepti Chugh,Subramaniam Ganesh

The Journal of comparative neurology 532:e25660 PubMed39039998

2024

Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-Cage Behavior.

Applications

Unspecified application

Species

Unspecified reactive species

Vaishnav Krishnan,Jun Wu,Arindam Ghosh Mazumder,Jessica L Kamen,Catharina Schirmer,Nandani Adhyapak,John Samuel Bass,Samuel C Lee,Atul Maheshwari,Gemma Molinaro,Jay R Gibson,Kimberly M Huber,Berge A Minassian

Cancer discovery 14:176-193 PubMed37931287

2023

Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Chunbo He,Dezhen Wang,Surendra K Shukla,Tuo Hu,Ravi Thakur,Xiao Fu,Ryan J King,Sai Sundeep Kollala,Kuldeep S Attri,Divya Murthy,Nina V Chaika,Yuki Fujii,Daisy Gonzalez,Camila G Pacheco,Yudong Qiu,Pankaj K Singh,Jason W Locasale,Kamiya Mehla

Foods (Basel, Switzerland) 12: PubMed37893745

2023

Effects of Cinnamon Powder on Glucose Metabolism in Diabetic Mice and the Molecular Mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Yaoyao Liu,Fan Liu,Dongxu Xing,Weifei Wang,Qiong Yang,Sentai Liao,Erna Li,Daorui Pang,Yuxiao Zou

The Journal of biological chemistry 299:105219 PubMed37660913

2023

PER2/P65-driven glycogen synthase 1 transcription in macrophages modulates gut inflammation and pathogenesis of rectal prolapse.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao Ding,Wenhao Ge,Xiaodong Xu,Xi Xu,Shiming Wang,Jianfa Zhang

Cancer & metabolism 11:9 PubMed37443106

2023

BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jiamin Zhong,Luyao Tian,Yannian Gou,Piao Zhao,Xiangyu Dong,Meichun Guo,Guozhi Zhao,Aohua Li,Ailing Hao,Tong-Chuan He,Jiaming Fan

Current issues in molecular biology 45:5613-5630 PubMed37504270

2023

A Prochlorperazine-Induced Decrease in Autonomous Muscle Activity during Hindlimb Unloading Is Accompanied by Preserved Slow Myosin mRNA Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Kristina A Sharlo,Irina D Lvova,Sergey A Tyganov,Ksenia V Sergeeva,Vitaly Y Kalashnikov,Ekaterina P Kalashnikova,Timur M Mirzoev,Grigoriy R Kalamkarov,Tatiana F Shevchenko,Boris S Shenkman

International journal of molecular sciences 24: PubMed37046993

2023

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.

Applications

Unspecified application

Species

Unspecified reactive species

Mireia Moreno-Estellés,Ángela Campos-Rodríguez,Carla Rubio-Villena,Lorena Kumarasinghe,Maria Adelaida Garcia-Gimeno,Pascual Sanz
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com